Robert Pirker, MD
Department of Medicine I, Medical University of Vienna, Vienna, Austria
Robert Pirker is currently Professor of Medicine and Program Director for Lung Cancer at the Department of Medicine I, Medical University of Vienna, Austria. He obtained a master’s degree in Biochemistry in 1978 and his medical degree in 1979 from the University of Vienna. Robert Pirker trained in Internal Medicine, Hemato-Oncology and Nuclear Medicine at the University of Vienna. He also worked as NIH Visiting Fellow at the Laboratory of Molecular Biology (Chief: Dr. Ira Pastan), National Cancer Institute, Bethesda, MD, USA (1983-86). His research interests are chemotherapy and targeted therapy of lung cancer, drug resistance mechanisms of cancer, and management of chemotherapy-induced anaemia. He has published more than 190 articles, reviews or book chapters. He has been an ESMO Faculty Member on Chest Tumors and a member including chair of the IASLC Education Committee. He is a current member of the IASLC Board of Directors. He was Congress President of the 8th and 14th Central European Lung Cancer Congresses, Chair of the Scientific Committee of the European Multidisciplinary Conference on Thoracic Oncology in 2009, and Conference President of the IASLC 17th World Conference on Lung Cancer in 2016 in Vienna, Austria.